text_1: NAC inhibits the generation of angiotensin-converting enzyme.
text_2: CONCLUSION Acetylcysteine protects patients with moderate chronic renal insufficiency from contrast-induced deterioration in renal function after coronary angiographic procedures, with minimal adverse effects and at a low cost.